Research fuels our mission to end cancer
Many of the greatest minds in cancer research are at MD Anderson. They're here because MD Anderson offers a unique environment that accelerates their ability to end cancer. They collaborate with other cancer experts – in different research areas and with the world's leading cancer doctors. Bright students and trainees contribute further to our dynamic research environment. Discoveries are fueled by vast research support and resources. Tomorrow's medicine is available to our patients first since we have the most cancer clinical trials in the world. These research efforts work in parallel to fight cancer through prevention, early diagnosis, effective therapies and scientific breakthroughs.
2018 CPRIT Funding
for individual investigator research
for colorectal cancer prevention
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded MD Anderson with $22.3 million, reflecting the importance and impact of our research. Fifteen MD Anderson faculty received individual investigator awards and $2 million was granted to recruit a top prostate cancer research expert.Learn more about our CPRIT funding
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
Hepatitis C and cancer
Peter WT Pisters, M.D.
Moon Shots Program
Inspired by an unprecedented era of scientific discovery a generation ago, the Moon Shots Program™ was launched by MD Anderson as an ambitious plan to make a giant leap in cancer research to benefit patients.Learn more about the Moon Shots Program
MD Anderson research labs lead cancer care into the future
In fiscal year 2017, MD Anderson invested more than $844 million in research. The discoveries made in our labs span all cancer types and treatment options. Read about some of the studies yielding fascinating and exciting results.
Jim Allison's Research
Immunotherapy pioneer named among TIME's 100 most influential people